Cornelia de Lange syndrome 1 is a rare genetic condition that affects growth and development. Many people with Cornelia de Lange syndrome 1 have small stature, distinctive facial features, and limb differences, and may have feeding issues and developmental delays. Signs usually begin before birth or in early infancy and continue lifelong, though severity can vary. Care focuses on supportive therapies, such as feeding support, early intervention, educational services, and treatment of heart, hearing, vision, or gastrointestinal problems. The outlook depends on how severe the features are, and many people live into adulthood with ongoing medical and developmental care.
Overview
Cornelia de lange syndrome 1Symptoms
Cornelia de Lange syndrome 1 usually shows from birth or early infancy with slow growth, feeding trouble, and distinctive facial features. Some have small or missing forearms or fingers, hearing loss, heart or gut issues, and developmental and learning differences.
Outlook and prognosis
Many living with Cornelia de Lange syndrome 1 grow and learn at their own pace, with wide variation in abilities. Early therapies, hearing and vision support, and attentive cardiac and gastrointestinal care can improve comfort, communication, and independence. Lifespan ranges from childhood to adulthood, depending on medical complications and care.
Causes and risk factors
Cornelia de Lange syndrome 1 usually results from a new change in the NIPBL gene. It can be inherited in an autosomal-dominant pattern if a parent carries the variant, including rare germline mosaicism. No known environmental or lifestyle risk factors.
Genetic influences
Genetics play a central role in Cornelia de Lange syndrome 1. Most cases result from new (de novo) changes in genes that control how chromosomes are organized, especially NIPBL; inheritance is usually autosomal dominant but familial cases are uncommon. Genetic testing confirms diagnosis and guides counseling.
Diagnosis
Doctors suspect Cornelia de Lange syndrome 1 from characteristic facial features, growth restriction, limb differences, and development. Genetic diagnosis of Cornelia de Lange syndrome 1 is confirmed by a disease-causing gene change; imaging and hearing or vision tests guide care.
Treatment and drugs
Treatment for Cornelia de Lange syndrome 1 focuses on supporting growth, learning, and comfort through a coordinated care plan. Many benefit from early therapies, hearing and vision support, feeding help, seizure management, and individualized education. Regular check-ins guide adjustments as needs change.
Symptoms
Many families first notice feeding challenges, slower weight gain, or distinctive facial traits in infancy. In daily routines, this might show up as small but noticeable changes. These are common early features of Cornelia de Lange syndrome 1. The pattern and severity differ widely, even within the same family.
Arched eyebrows that may meet, long eyelashes, a short upturned nose, a thin upper lip, and extra body hair are typical. These traits help doctors recognize Cornelia de Lange syndrome 1 but do not by themselves affect a child’s abilities.
Many are smaller before birth and grow more slowly afterward. Adult height is often shorter than average. This growth pattern is common in Cornelia de Lange syndrome 1.
Some have small forearms or hands, missing fingers or thumbs, or limited elbow movement. Everyday tasks like buttoning, feeding, or writing may need adaptations. Occupational therapy and assistive tools often help.
In infancy, weak suck, trouble coordinating swallowing, and acid reflux are common. Meals can take longer and weight gain may be slow. These feeding challenges are frequent in Cornelia de Lange syndrome 1.
How people usually first notice Cornelia de lange syndrome 1?
Families often first notice Cornelia de Lange syndrome 1 in the newborn period because of distinctive facial features and small size for age, sometimes alongside feeding difficulties or a weak cry. Doctors may recognize the first signs of Cornelia de Lange syndrome 1 at birth or soon after, such as fused or arched eyebrows, long eyelashes, small hands and feet, limb differences, or poor weight gain, and may confirm concerns with genetic testing. In some cases, how Cornelia de Lange syndrome 1 is first noticed happens during pregnancy when an ultrasound shows growth restriction or limb anomalies, prompting closer monitoring and postnatal evaluation.
Types of Cornelia de lange syndrome 1
Cornelia de Lange syndrome 1 is a genetic condition with recognized variants that can look different in day-to-day life, from growth and learning differences to limb or facial features. Variants are usually defined by the gene involved and how strongly a change in that gene disrupts development. Not everyone will experience every type. Here are the main types to know about:
NIPBL classic
This variant is the most common and often linked to more noticeable features and medical needs. People may have shorter height, distinct facial traits, feeding issues in infancy, and limb differences.
NIPBL milder
Changes that partially affect NIPBL can lead to a milder presentation. Many have fewer limb differences and more subtle facial features, with learning support needs that vary.
SMC1A-related
This X-linked variant often shows milder growth and limb findings compared with classic NIPBL. People may have developmental delays and distinctive facial traits, with possible seizure risk.
SMC3-related
Typically associated with a milder form. People may have developmental and behavioral differences with fewer structural anomalies.
RAD21-related
Often milder overall, with learning and speech delays more prominent. Physical features can be subtler, and limb differences are less common.
BRD4-related
Usually on the milder end with overlapping facial features and learning differences. Some may have heart or feeding issues early in life.
HDAC8-related
This X-linked variant can include distinctive facial features and joint laxity. People may have variable growth, developmental delays, and sometimes seizures.
Clinical spectrum
Clinicians often group these into types: classic, non-classic, and mild, reflecting overall severity across genes. This helps explain types of Cornelia de Lange syndrome 1 that differ mainly in how strongly features appear.
What genetics can tell you about symptoms
Some people with Cornelia de Lange syndrome 1 (caused by NIPBL gene changes) have distinctive facial features, short stature, limb differences, feeding issues, and developmental delays because the gene’s disruption alters how many body parts grow and coordinate. Certain variants tend to cause more severe growth and limb differences, while milder changes may mainly affect learning and behavior.
Causes and risk factors
The genetic causes of Cornelia de Lange syndrome 1 usually involve a new change in a gene called NIPBL. This change happens around conception and is not linked to anything the parents did. Rarely, the change is inherited, or a parent may carry it in some of their egg or sperm cells, which can raise the chance in future pregnancies. There are no known lifestyle, diet, or environmental causes of Cornelia de Lange syndrome 1, and severity can vary from mild to severe. Genetic testing can sometimes clarify your personal risk.
Environmental and biological risk factors
If you’re planning a pregnancy, it’s natural to ask what can raise the chances of Cornelia de Lange syndrome 1. Doctors often group risks into internal (biological) and external (environmental). For this condition, most cases arise spontaneously very early in development, and researchers have not identified clear environmental risk factors for Cornelia de Lange syndrome 1. A few biological factors may slightly shift the odds.
As men get older, spontaneous DNA changes in sperm become more common, which can slightly raise the chance of this condition. The absolute risk remains low for any single pregnancy, but it increases gradually with paternal age.
No specific environmental risk has been confirmed to increase the likelihood of this condition. Studies to date have not found consistent links with medications, infections, air pollution, or workplace exposures.
Genetic risk factors
Cornelia de Lange syndrome 1 is most often linked to a harmful change in a gene called NIPBL, which guides early development. Some risk factors are inherited through our genes. Most changes happen for the first time in a child (a new, or “de novo,” change), though a parent can sometimes carry the change and pass it on. Understanding the genetic causes of Cornelia de Lange syndrome 1 can help families make sense of personal and sibling risks.
NIPBL gene changes: A harmful change in the NIPBL gene disrupts how cells control early growth and development. This is the primary genetic cause of Cornelia de Lange syndrome 1. Different changes in this gene can lead to a wide range of features.
Dominant inheritance: Having one altered copy of NIPBL is enough to cause the condition. If a parent has the change, each pregnancy has a 50% chance of Cornelia de Lange syndrome 1.
De novo changes: In most families, the NIPBL change is new in the child and not present in either parent. This explains why many people with Cornelia de Lange syndrome 1 have no prior family history.
Germline mosaicism: A parent can carry the change in some egg or sperm cells but not in standard blood testing. This creates a small recurrence risk (about 1% to 2%) even when both parents test negative.
Somatic mosaicism: Some people have the NIPBL change in only a portion of their cells, which can lead to milder features. Standard blood tests may miss the change, so testing other tissues can sometimes be helpful.
Type of change matters: Changes that strongly disrupt NIPBL often cause more pronounced features. Subtle changes may be linked to milder presentations, though there is broad overlap.
Gene deletions: Rarely, a small missing segment of chromosome 5 that includes NIPBL causes Cornelia de Lange syndrome 1. The size of the missing segment can influence which additional features appear.
Variable expressivity: People with the same NIPBL change can have very different features and severity. This makes it difficult to predict exact outcomes within a family.
Lifestyle risk factors
Lifestyle habits do not cause Cornelia de Lange syndrome 1, but daily routines can influence comfort, behavior, growth, and complication risks. Understanding how lifestyle affects Cornelia de Lange syndrome 1 helps tailor care to feeding challenges, reflux, sleep issues, and sensory sensitivities common in this condition. Choices around nutrition, activity, sleep, and communication can meaningfully ease symptoms and support development. Adjustments should be individualized and coordinated with the care team.
Nutrient-dense foods and adequate protein can support growth in children with feeding difficulties and high energy needs. Sufficient fiber and fluids can ease constipation that is common in CdLS1.
Small, frequent meals can reduce reflux and vomiting that aggravate discomfort and feeding aversion. Unhurried, predictable mealtime routines may lessen gagging and improve intake.
Upright positioning during and after meals can lower reflux and aspiration risk in CdLS1. Consistent safe-swallow strategies can reduce coughing, choking, and respiratory complications.
Regular fluid intake can prevent dehydration-related irritability and constipation in CdLS1. Adequate hydration also supports saliva flow, which can improve oral comfort and feeding.
Risk prevention
Cornelia de Lange syndrome 1 is a genetic condition that cannot be prevented, but many complications can be reduced with early, proactive care. Prevention works best when combined with regular check-ups. Recognizing early symptoms of Cornelia de Lange syndrome 1 can lead to timely support, which often improves feeding, growth, breathing, hearing, and learning. Families can also plan future pregnancies with genetic counseling and testing to understand and lower the chance of recurrence.
Meet with a genetics team to understand why Cornelia de Lange syndrome 1 happens and the chance of it occurring again. They can discuss testing for the known family variant, preimplantation genetic testing, and prenatal options.
If a family variant is known, testing during pregnancy (CVS or amniocentesis) can check the fetus. Detailed ultrasounds can also look for features linked with Cornelia de Lange syndrome 1.
Keep routine vaccines up to date to lower the risk of pneumonia, flu, and ear infections. Fewer infections can protect growth, breathing, and hearing in children with Cornelia de Lange syndrome 1.
Practice handwashing and prompt treatment for ear, sinus, and chest infections. Reducing infections helps prevent breathing problems and hospital stays.
Transmission
Cornelia de Lange syndrome 1 is not contagious. It happens because of a change in a gene important for early development, and in most people this change is new in the child and not inherited from either parent. If a parent does carry the same gene change, each pregnancy has a 1 in 2 (50%) chance of inheriting Cornelia de Lange syndrome 1. In some families, a parent may have the change in only some cells (mosaicism), which can raise the chance of having another child with the condition even if routine blood testing in the parent is negative. If you want clear, family-specific guidance on how Cornelia de Lange syndrome 1 is inherited, a genetics professional can explain the genetic transmission of Cornelia de Lange syndrome 1 and discuss testing options.
When to test your genes
Consider genetic testing if a newborn shows features of Cornelia de Lange syndrome (CdLS)—such as slow growth, distinct facial appearance, limb differences, or feeding challenges—or if a clinician suspects CdLS based on development. Testing also helps confirm a diagnosis, guide care, and inform family planning, including recurrence risk.
Diagnosis
Families often notice early feeding troubles, slow growth, or distinctive facial traits before anyone names what’s going on. With Cornelia de Lange syndrome 1, doctors combine what they see in an exam with specific tests to confirm the cause. Early and accurate diagnosis can help you plan ahead with confidence.
Doctors look for a consistent pattern of facial traits, limb differences, slow growth, and developmental delays. Structured checklists and body measurements help show whether the overall pattern fits this syndrome.
A blood test checks for changes in the NIPBL gene and related genes known to cause this condition. If blood testing is inconclusive, testing a second tissue such as a cheek swab may be considered to look for mosaic changes.
During pregnancy, ultrasound may show slow growth, limb differences, or certain organ findings that raise suspicion. If concerns arise, diagnostic testing of the pregnancy can be offered to confirm the cause.
Heart and kidney imaging can identify features that commonly occur with this syndrome. These findings support the clinical picture and guide early care plans.
Stages of Cornelia de lange syndrome 1
Cornelia de lange syndrome 1 does not have defined progression stages. It’s a genetic condition present from birth, and while features can change with age, it follows a spectrum of severity rather than a step-by-step decline. Doctors usually make the diagnosis based on a hands-on exam, growth patterns, limb differences, facial features, and developmental history, and they look for early symptoms of Cornelia de lange syndrome 1 in infancy and early childhood. Different tests may be suggested to help confirm the diagnosis and guide care, including genetic testing and checks of hearing, heart, feeding, and growth.
Outlook and prognosis
Many living with Cornelia de Lange syndrome 1 (CdLS1) grow and learn at their own pace, with wide differences in speech, motor skills, and independence from one person to the next. The outlook is not the same for everyone, but most children with CdLS1 survive into adulthood, especially with good nutrition, hearing and vision support, and proactive care for heart, feeding, and breathing issues. Early symptoms of Cornelia de Lange syndrome 1 can include feeding challenges, slow growth, and developmental delays; addressing these early often improves comfort and long-term function. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.
Looking at the long-term picture can be helpful. For many, health needs are ongoing—regular checks for reflux, constipation, dental issues, hearing loss, and behavior or sleep concerns can prevent small problems from becoming big ones. Some people experience more medical complications, particularly if there are congenital heart or airway differences, while others notice milder courses with fewer hospital visits. Severe forms present the highest medical risk in infancy, when breathing or feeding problems can affect survival; beyond that period, life expectancy generally improves and depends on the number and severity of organ-related complications.
With ongoing care, many people maintain meaningful routines at home, school, and supported work as adults, though independent living is less common. People living with this condition often benefit from therapies that build communication—spoken words, sign, or devices—because better communication can reduce frustration and improve quality of life. Talk with your doctor about what your personal outlook might look like. Genetic testing can sometimes provide more insight into prognosis, but not everyone with the same gene change will have the same outlook.
Long-term effects
Living with Cornelia de Lange syndrome 1 often involves changes that unfold from infancy into adulthood. Long-term effects vary widely, and outlook depends on overall severity and which organs are involved. Many people reach adulthood, though some need ongoing medical, educational, and communication support. Many families first notice early symptoms of Cornelia de Lange syndrome 1 in infancy, and certain features may become more apparent over time.
Lifelong short stature is common, with slower weight gain and height growth than peers. Head size may remain smaller than average.
Global developmental delay and intellectual disability often persist into adulthood. Learning usually progresses, but at a slower pace and with uneven strengths.
Speech may be delayed or limited, and some rely on alternative communication methods. Understanding language is often better than expressive speech.
Many have features of autism spectrum, anxiety, or repetitive behaviors. Emotional regulation can be challenging during childhood and adolescence.
How is it to live with Cornelia de lange syndrome 1?
Living with Cornelia de Lange syndrome 1 often means moving at a different pace, with challenges in growth, learning, communication, and sometimes feeding or hearing that shape daily routines from early childhood onward. Many families build structured days with therapies, visual supports, and extra time for transitions, which can ease frustration and help children participate in school and community life. People around them—parents, siblings, teachers, caregivers—often become skilled advocates, adjusting expectations, celebrating small steps, and coordinating medical and developmental care. While the workload can be heavy at times, connection with knowledgeable clinicians, early intervention, and support networks can make everyday life more predictable, safer, and more joyful.
Treatment and drugs
Treatment for Cornelia de Lange syndrome 1 focuses on easing symptoms, supporting development, and preventing complications over time. Care often starts early with a coordinated team—pediatricians, geneticists, therapists, audiology and vision specialists, dentists, and sometimes heart or gastrointestinal doctors—so speech therapy, occupational and physical therapy, feeding support, hearing aids, glasses, or orthopedic care can be put in place as needed. Doctors sometimes recommend a combination of lifestyle changes and drugs, such as medicines for reflux or constipation, seizure control, sleep difficulties, attention or anxiety symptoms, and spasticity or muscle tightness. Surgery may be considered for specific issues (for example, cleft palate repair, limb differences, significant reflux, or undescended testes), and regular monitoring of growth, hearing, vision, heart, and behavior helps adjust care as needs change. Not every treatment works the same way for every person, so keeping track of responses and side effects and updating the plan with your care team is key.
Non-drug treatment
Living with Cornelia de lange syndrome 1 often means building a supportive care plan that fits daily life at home, school, and in the community. Non-drug treatments often lay the foundation for communication, movement, feeding, sleep, and behavior. These approaches usually work best when started early and adjusted over time as needs change. Not every approach works the same way for every child or adult, so teams personalize care and track progress together.
Starting therapies in infancy can boost developmental skills during key growth windows. Early symptoms of Cornelia de lange syndrome 1 can be subtle, so early referral helps catch needs sooner. Services often include home or clinic visits with a coordinated team.
Gentle exercises help with strength, balance, and posture to support sitting, standing, and walking. Therapists tailor activities to joint flexibility and motor delays. Braces or shoe inserts may be used to steady alignment.
Practice with hand skills and daily tasks builds independence in dressing, feeding, and play. Therapists adapt tools and seating to fit smaller hands or limb differences. Sensory strategies can help with touch or sound sensitivities.
Therapy targets speech sounds, understanding language, and social communication. If speech is limited, therapists introduce picture boards or speech-generating devices. Feeding and swallowing skills can be addressed during sessions.
Your genes may have an impact on how drugs work for you
Medications used in Cornelia de Lange syndrome 1 can act differently because gene changes may alter how the body absorbs, breaks down, or responds to drugs. This is why clinicians start low, go slow, and individualize dosing, especially for sedation, pain medicines, and behavioral treatments.
Pharmacological treatments
Medicines for Cornelia de Lange syndrome 1 focus on easing day-to-day challenges like reflux, seizures, constipation, sleep problems, and behavior changes rather than changing the condition itself. Not everyone responds to the same medication in the same way. Your team will tailor choices to age, symptom pattern, and other health needs, and adjust over time. This often targets issues that overlap with early symptoms of Cornelia de Lange syndrome 1, such as feeding discomfort or poor sleep.
Proton pump inhibitors like omeprazole, esomeprazole, or lansoprazole reduce stomach acid and ease heartburn and feeding discomfort. Famotidine may help if PPIs aren’t tolerated. Simple feeding changes often add benefit.
Levetiracetam, valproate, or lamotrigine are common options to prevent seizures. Choice depends on seizure type and side effects. Blood tests may be needed with valproate.
Polyethylene glycol or lactulose softens stools and makes bowel movements more regular. Senna or bisacodyl can be used short-term if stools are very hard. Good fluid and fiber intake helps these work better.
SSRIs such as sertraline or fluoxetine can reduce anxious distress, repetitive thoughts, and irritability. Doses usually start low and increase slowly to limit side effects. Watch for sleep or appetite changes.
Genetic influences
Cornelia de Lange syndrome 1 is caused by a change in a gene called NIPBL, and in most cases this change is new in the child rather than inherited from a parent. If a parent does carry the NIPBL change, each pregnancy has a 50% chance of inheriting it (this pattern is known medically as autosomal dominant). Rarely, the change is present in only some of a parent’s cells—called mosaicism—which may cause few or no features and can be hard to detect on a routine blood test, slightly raising the chance of it happening again. Even with the same gene change, people can have very different features and levels of support needed. Genetic testing for Cornelia de Lange syndrome 1 usually looks for NIPBL changes and can confirm the diagnosis; in some situations, testing more than one tissue (for example, blood and a cheek swab) helps find low-level mosaic changes. Knowing whether the change was inherited or happened for the first time can guide family planning and who in the family might benefit from testing.
Is Cornelia de lange syndrome 1 genetic?
Genetics play a central role in Cornelia de Lange syndrome 1. Most cases result from new (de novo) changes in genes that control how chromosomes are organized, especially NIPBL; inheritance is usually autosomal dominant but familial cases are uncommon. Genetic testing confirms diagnosis and guides counseling.
Pharmacogenetics—how genetics influence drug effects
Treatment for Cornelia de Lange syndrome 1 is tailored to each person’s needs, and genetics can sometimes help fine‑tune medicine choices. The gene change that causes this condition doesn’t usually alter the liver pathways that break down drugs, but other inherited differences can affect how you respond to medicines used for reflux, seizures, sleep, pain, or behavior. Genetic testing can sometimes identify how your body processes certain medicines and point to safer starting doses. For example, some pain relievers need to be converted by the body to work, and some seizure or mood medicines are cleared more quickly or more slowly depending on your genes; this can influence side effects and the dose that works best. Pharmacogenetic testing in Cornelia de Lange syndrome 1 doesn’t replace careful monitoring, because body size, feeding challenges, heart or airway differences, and other health factors also guide dosing and anesthesia planning. Genetics can add another layer of safety and predictability, especially when multiple medicines are needed, while your care team adjusts treatment based on day‑to‑day response.
Interactions with other conditions
People living with Cornelia de Lange syndrome 1 often have other health issues that interact with daily life, so one problem can ripple into another. Reflux and feeding difficulties can worsen growth concerns, raise the risk of breathing food or liquid into the lungs, and lead to repeated chest infections; when reflux is under control, many families notice sleep and feeding improve as well. Heart differences and airway narrowing are not unusual, and they matter during colds, surgeries, or anesthesia, when breathing can be more difficult and careful planning is essential. Doctors call it a “comorbidity” when two conditions occur together, and in Cornelia de Lange syndrome 1, seizures, hearing and vision problems, and autism‑spectrum features can overlap, sometimes making communication, behavior, and learning supports more complex to coordinate.
Some medicines used for seizures or behavior can increase drowsiness or reduce appetite, which may complicate feeding therapy or sleep apnea management, so teams often adjust doses slowly and monitor closely. Infections, constipation, or pain from reflux can also “turn up the volume” on challenging behaviors, which is one reason early symptoms of Cornelia de Lange syndrome 1 can be hard to separate from the effects of another illness. With coordinated care across pediatrics, cardiology, gastroenterology, neurology, audiology, and behavioral health, many people live well despite having both Cornelia de Lange syndrome 1 and other conditions.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described children who were small at birth, with distinctive facial features and slower development, long before Cornelia de Lange syndrome 1 had a name. Families noticed patterns that seemed to “run” through branches of a family tree, while others saw it appear for the first time in a child with no known family history. In everyday life this meant parents comparing baby photos, or teachers recalling a student who needed extra support and had very small hands and a soft, low voice.
First described in the medical literature as a cluster of features seen in a few children in the 1930s, the condition was initially understood through careful observation—growth that lagged behind peers, differences in limb size, feeding difficulties, and a recognizable facial look. Over time, descriptions became more detailed and more inclusive. Clinicians broadened their notes to include how speech and learning developed, how behavior varied, and how some people had very mild features while others had more visible differences.
As medical science evolved, what started as a “pattern recognition” diagnosis moved toward clearer categories. Doctors learned that Cornelia de Lange syndrome 1 could range from subtle to more severe. Early reports highlighted limb differences and strong facial similarities; later work showed that heart, stomach, and hearing issues could also be part of the picture, and that not everyone had the same combination. This shift helped families understand why two people with the same condition might have very different day-to-day needs.
Advances in genetics in the late 20th and early 21st centuries changed the story yet again. Researchers linked many cases of Cornelia de Lange syndrome to changes in a gene now known to help control how other genes turn on and off, working a bit like a dimmer switch. This discovery explained why the condition could appear in a child with no family history—new, “de novo” changes can arise in a single egg or sperm—or sometimes be inherited. It also clarified why features vary so widely: different changes in the same gene can affect the body to different degrees.
From early theories to modern research, the story of Cornelia de Lange syndrome 1 reflects how medicine grows—starting with attentive observation, then refining definitions, and finally uncovering biologic causes. Knowing the condition’s history helps explain today’s approach: look at the whole person, not just one feature; consider both medical and developmental needs; and offer genetic testing when helpful, alongside practical, family-centered care.